immunohistochemistry
Ventana Licenses Gen-Probe IP for Measuring ERG Protein in Prostate Cancer Patients
Ventana Medical Systems Inc., a member of the Roche Group, announced that it has co-exclusively sub-licensed certain patents and patent applications from Gen-Probe Inc. for the worldwide IVD rights for measuring ERG protein expression through immunohistochemistry (IHC) in prostate tissue. The license complements the existing Ventana sublicense for in situ hybridization (ISH) rights for measuring ETS gene rearrangements, including ERG gene rearrangements in tissue. Ventana believes that...